Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Clondalkin Group and Pharma Prospect announce strategic alliance

The international producer of high value-added packaging solutions Clondalkin Group has joined forces with Spanish based print manufacturer Pharma Prospect in a strategic alliance to develop and strengthen its Pharma and Healthcare business across Europe.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The associate marketing agreement will allow Clondalkin Group to further strengthen its growing Pharma & Healthcare business by widening its customer portfolio across Europe.

Pharma Prospect, located in Barcelona, manufacture a full range of printed paper leaflets which are supported by extensive design, pre-press, supply chain management and packaging system services.

Clondalkin Group is a market leader in secondary healthcare packaging. The Group's Pharma & Healthcare division is a global supplier of cartons, labels and literature and operates 17 accredited Pharma & Healthcare sites throughout North America and Europe, including a market leading carton operation in Spain formerly known as Cartonplex, which is also based in Barcelona.

Malcolm Farnan, Sales & Marketing Director from Clondalkin Group, commenting on the partnership said; "We are very pleased to form this strategic alliance. Pharma Prospect specialise in the manufacture of print solutions to some of the world's leading manufacturers in the pharmaceutical, medical device, healthcare and cosmetic industries and therefore complement our own capabilities perfectly.   Like us, they focus on providing innovative, value added packaging solutions and developing strong and long-lasting customer relationships.

"By working together and effectively promoting each other's skills and expertise, the agreement will enable both parties to realise new opportunities and strengthen our growth strategies in Europe," Malcolm continued.

Tony Pirretas, Director General at Pharma Prospect added; "This agreement will enable us to build a strong team in the Spanish pharmaceutical market. It will strengthen our credibilty and demonstrate to our customers our commmitment to become a market leading global packaging supplier".

Clondalkin Group's Specialist Packaging Division has 25 production sites throughout North America and Europe and includes folding cartons, labels, leaflets, literature and inserts/outserts businesses, along with paper packaging and printing components.

Clondalkin Group's Pharma & Healthcare Global CEO, David Lennon concluded; "This alliance with Pharma Prospect is part of our stated objective to become the global leader in the supply of secondary packaging to the Pharma & Healthcare sector."
 

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging